- DESCRIPTION
- TABLE OF CONTENTS
- METHODOLOGY
- DOWNLOAD PDF
Biomaterials Market by Type [Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)], Application (Orthopedic, Dental, CVD, Ophthalmology) - Global Forecast to 2030
USD 68.93 BN
MARKET SIZE, 2030
CAGR 7.3%
(2025-2030)
665
REPORT PAGES
908
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global biomaterials market, valued at USD 45.15 billion in 2024, stood at USD 48.36 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of USD 68.93 billion by the end of the period. Biomaterials are specially crafted materials designed to interact safely with biological systems for medical applications. These substances are engineered for biocompatibility with living tissues and support diverse uses, including implants, prosthetics, drug delivery systems, and tissue engineering.
KEY TAKEAWAYS
-
BY REGION
The Asia Pacific is the fastest-growing regional segment with a CAGR of 7.8% during the forecast period.
-
BY TYPE
By type, metallic biomaterials are projected to show the highest CAGR of 7.6% between 2025 and 2030.
-
BY APPLICATION
By application, the orthopedic segment is expected to dominate the global biomaterials market in 2024 with a CAGR of 34.9%.
-
COMPETITIVE LANDSCAPE
BASF SE, Celanese corporation, Carpenter technology, were identified as some of the star players in the global biomaterials market, given their strong market share and product footprint.
-
COMPETITIVE LANDSCAPE
Collagen Solution and Jellatech have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The global biomaterials market is expanding rapidly, driven by the surge in precision-medicine programs and the routine use of biomarker-guided tests in oncology, cardiology, and other complex diseases.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The biomaterials market is emerging with innovative developments and smart applications of technology, processing, and regulations that work in perfect synchrony with precision medicine, tissue-engineered therapies, and complex biologic treatments. The large and ever-expanding patient base across the global healthcare systems, fighting cancer, cardiovascular diseases, musculoskeletal diseases requiring orthopedic interventions, and neurological disorders, is driving the need for superior biomaterials with a proven track record of reliable and durable clinical outcomes through innovative biomaterials in the form of implants, scaffolds, and drug-delivery devices. Clinically proven and automation-friendly products such as bioresorbable polymers, bioactive ceramics, and collagen bioengineered scaffolds are also gaining increasing acceptances, as they enhance procedures, help with personalized and minimally invasive procedures aligned with the regulator and payer communities in developed regions such as Asia Pacific and North America.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
-
Rising advancements in smart, biocompatible, and 3D-printed biomaterials
-
Advancements in healthcare facilities and systems
RESTRAINTS
Impact
Level
-
High development and production costs associated with advanced biomaterials
OPPORTUNITIES
Impact
Level
-
Expanding applications in tissue engineering and regenerative medicine
CHALLENGES
Impact
Level
-
Concerns related to biocompatibility, safety, and adverse immune responses
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Innovations in smart biocompatible and 3D-printed biomaterials are driving market growth, yielding improved clinical outcomes through bioresorbable polymers, surface-modified implants, and expanded applications.
High development and production costs for advanced biomaterials, along with complex regulatory approvals, limit scalability and market penetration.
Biomaterials applications in tissue engineering, regenerative medicine, and personalized therapy represent a significant area of growth potential amidst the rising prevalence of chronic diseases.
Biocompatibility issues, immune reactions, and variability in long-term performance pose ongoing hurdles to the widespread adoption.
BIOMATERIALS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Produces biodegradable lactic acid-based biomaterials (PLA and related polymers) used in controlled drug delivery, tissue regeneration, and resorbable implants. | Enables biodegradable implant solutions that support tissue healing and reduce long-term foreign body presence. |
|
|
Manufactures specialty biomaterial polymers for applications in tissue engineering, drug delivery systems, and medical devices. | Enhances material performance with tailored degradation rates, mechanical strength, and biocompatibility for varied clinical needs. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The global biomaterials market is a highly interconnected market where material researchers, device makers, biotechnology and medical technology firms, research institutions, and physicians work together for the introduction of novel solutions based on biomaterials in medicine. Manufacturers, along with specialty material suppliers, offer high-performance polymer, metal, ceramic, and natural biomaterials. Contract research organizations, contract development and manufacturing organizations, and academic research facilities assist in preclinical studies, clinical studies, and commercialization for implants, drug delivery systems, and regenerative medicine based on biomaterials. European medical facilities, reference, and reimbursement systems translate clinical confirmations for biomaterials into practical, innovative, precision medicine for Europe on a daily basis through their normal operations.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
In 2024, metallic biomaterials dominated due to the wide use of metals in the manufacturing of medical devices for cardiovascular, dental, and orthopedic applications.
In 2024, the orthopedic segment accounted for the largest share of the biomaterials market. Its market leadership can be attributed to the increasing prevalence of orthopedic conditions, such as osteoarthritis, osteoporosis, and musculoskeletal injuries.
REGION
APAC to be fastest-growing region in market during forecast period
In 2024, the APAC region emerged as the fastest-growing in the global biomaterials market, driven by its dense network of academic medical centers, specialized surgical hospitals, and dynamic life-science innovation hubs. A robust pipeline of orthopedic, cardiovascular, dental, and regenerative therapies, paired with significant investments in personalized medicine and extensive clinical trials, fuels this surge.
BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX
In the global biomaterials market, BASF leads as the star player, leading the polymer segment with its extensive lineup of medical-grade plastics and superabsorbent materials that hospitals and device OEMs worldwide trust for wound-care dressings, surgical pads, and reliable components in drug-delivery and surgical instruments. Mitsubishi Chemical emerges as a rising leader, building momentum via its specialty metal and biomaterial units that deliver precision alloys, implantable textiles, and polymer scaffolds, enabling MedTech and biopharma partners across key regions to pioneer next-gen cardiovascular, orthopedic, and cell-therapy devices.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- BASF SE (Germany)?
- COVESTRO AG (Germany)
- CELANESE CORPORATION (US)?
- CARPENTER TECHNOLOGY CORPORATION (US)?
- Evonik Industries (Germany)
- DSM (Netherlands)
- Corbion NV(Netherlands)
- Victrex PLC(UK)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2024 (Value) | USD 45.15 Billion |
| Market Forecast in 2030 (Value) | USD 68.93 Billion |
| Growth Rate | CAGR of 7.3 % from 2025-2030 |
| Years Considered | 2023-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD Million/Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Related Segment & Geographic Reports |
Orthopedic Biomaterials Market North America Biomaterials Market Europe Biomaterials Market Asia Pacific Biomaterials Market Polymeric Biomaterials Market |
WHAT IS IN IT FOR YOU: BIOMATERIALS MARKET: REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Benchmarking end-user preferences for biomaterial types and applications | Mapped how surgeons, interventional cardiologists, and dental specialists prioritize metallic, polymeric, ceramic, and natural biomaterials across orthopedic, cardiovascular, dental, and wound-healing procedures, including trade-offs in handling, longevity, and reimbursement | Informs portfolio strategy and clinical-education efforts by showing which biomaterial families are gaining share in each specialty, enabling commercial teams to target the right KOLs, procedures, and indication expansions with differentiated value messages |
| Identifying outsourcing and partnership opportunities for biomaterial-based device development | Mapped leading biomaterials-focused CDMOs and contract manufacturers and OEMs with polymer synthesis, implant forming, sterile packaging, and regulatory-compliant scale-up, highlighting examples such as Corbion, Life Science Outsourcing, Evonik, Regenity, and specialized bioresorbable-device developers. | Helps clients prioritize high-value partners for co-development and manufacturing, shortens time-to-market for new implants and scaffolds, and reduces capex by leveraging existing GMP infrastructure purpose-built for advanced biomaterials |
RECENT DEVELOPMENTS
- March 2023 : Celanese Corporation and Alessa Therapeutics have entered a collaboration to combine Alessa’s sustained, localized drug-delivery expertise with Celanese’s VitalDose EVA platform to develop a localized, sustained-release oncology drug-delivery system aimed at reducing systemic side effects for cancer patients
- April 2023 : Celanese Corporation signed an agreement with Glaukos to supply its VitalDose drug-delivery platform as a key component of Glaukos’ iDose TR, a micro-invasive intraocular implant designed to provide long-duration glaucoma therapy by continuously reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
15
2
EXECUTIVE SUMMARY
3
PREMIUM INSIGHTS
4
MARKET OVERVIEW
4.1
INTRODUCTION
4.2
MARKET DYNAMICS
4.2.1
DRIVERS
4.2.2
RESTRAINTS
4.2.3
OPPORTUNITIES
4.2.4
CHALLENGES
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNTIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.1
INTRODUCTION
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN THE GLOBAL BIOMATERIALS MARKET
5.3
VALUE CHAIN ANALYSIS
5.4
ECOSYSTEM ANALYSIS
5.5
PRICING ANALYSIS
5.5.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT (2022-2024)
5.5.2
AVERAGE SELLING PRICE TREND, BY REGION (2024)
5.6
TRADE ANALYSIS
5.6.1
IMPORT SCENARIO (HS CODE 7221)
5.6.2
EXPORT SCENARIO (HS CODE 7221)
5.7
KEY CONFERENCES AND EVENTS, 2025–2026
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10
IMPACT OF 2025 US TARIFF – GLOBAL BIOMATERIALS MARKET
5.10.2
INTRODUCTION
5.10.2
KEY TARIFF RATES
5.10.3
PRICE IMPACT ANALYSIS
5.10.4
IMPACT ON COUNTRIES
5.12.4.1
US
5.12.4.2
CANADA
5.11.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
PRECISION TECHNOLOGY
6.1.2
BIOMIMETICS
6.2
ADJACENT TECHNOLOGIES
6.2.1
3D BIOPRINTING
6.2.1
ELECTROSPINNING
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.4
PATENT ANALYSIS
6.5
FUTURE APPLICATIONS
6.6
IMPACT OF AI/GEN AI ON GLOBAL BIOMATERIALS MARKET
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
CASE STUDIES OF AI IMPLEMENTATION IN THE GLOBAL BIOMATERIALS MARKET
6.6.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE GLOBAL BIOMATERIALS MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2
INDUSTRY STANDARDS
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.3
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5
MARKET PROFITABILITY
9
GLOBAL BIOMATERIALS MARKET, BY TYPE, 2023-2030 (USD MILLION)
COMPARATIVE ASSESSMENT OF KEY PRODUCTS, THEIR MARKET POTENTIAL, AND REVENUE TRENDS
9.1
INTRODUCTION
9.2
METALLIC BIOMATERIALS
9.2.1
STAINLESS STEEL
9.2.2
TITANIUM & TITANIUM ALLOYS
9.2.3
COBALT-CHROME ALLOYS
9.2.4
SILVER
9.2.5
GOLD
9.2.6
MAGNESIUM
9.2.7
OTHER METALLIC BIOMATERIALS
9.3
POLYMERIC BIOMATERIALS
9.3.1
POLYMETHYLMETHACRYLATE (PMMA)
9.3.2
POLYETHYLENE
9.3.3
POLYESTER
9.3.4
POLYVINYLCHLORIDE
9.3.5
SILICONE RUBBER
9.3.6
NYLON
9.3.7
POLYETHERETHERKETONE (PEEK)
9.3.8
OTHER POLYMERIC BIOMATERIALS
9.4
CERAMIC BIOMATERIALS
9.4.1
CALCIUM PHOSPHATE
9.4.2
ZIRCONIA
9.4.3
ALUMINUM OXIDE
9.4.4
CALCIUM SULFATE
9.4.5
CARBON
9.4.6
GLASS
9.5
NATURAL BIOMATERIALS
9.5.1
HYALURONIC ACID
9.5.2
COLLAGEN
9.5.3
FIBRIN
9.5.4
CELLULOSE
9.5.5
CHITIN
9.5.6
ALGINATE
9.5.7
GELATIN
9.5.8
CHITOSAN
9.5.9
SILK
9.5.10
OTHER NATURAL BIOMATERIALS
11
GLOBAL BIOMATERIALS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
APPLICATION-WISE DEMAND POTENTIAL AND GROWTH PATHWAYS PHARMACEUTICAL FILTRATION ADOPTION IN DIVERSE INDUSTRIES
11.1
INTRODUCTION
11.2
CARDIOVASCULAR
11.2.1
CATHETERS
11.2.2
STENTS
11.2.3
IMPLANTABLE CARDIAC DEFIBRILLATORS
11.2.4
PACEMAKERS
11.2.5
SENSORS
11.2.6
HEART VALVES
11.2.7
VASCULAR GRAFTS
11.2.8
GUIDEWIRES
11.2.9
OTHER PRODUCTS
11.3
ORTHOPEDIC
11.3.1
JOINT REPLACEMENT
11.3.1.1
KNEE REPLACEMENT
11.3.1.2
HIP REPLACEMENT
11.3.1.3
SHOULDER REPLACEMENTS
11.3.1.4
OTHER JOINT REPLACEMENT APPLICATIONS
11.3.2
SPINE SURGERIES
11.3.2.1
SPINAL FUSION
11.3.2.2
MINIMALLY INVASIVE FUSION
11.3.2.3
MOTION PRESERVATION & DYNAMIC STABILIZATION
11.3.2.3.1
PEDICLE-BASED ROD SYSTEMS
11.3.2.3.2
INTERSPINOUS SPACERS
11.3.2.3.3
ARTIFICIAL DISCS
11.3.3
BIORESORBABLE TISSUE FIXATION
11.3.3.1
SUTURE ANCHORS
11.3.3.2
INTERFERENCE SCREWS
11.3.3.3
MENISCAL REPAIR TACKS
11.3.3.4
MESHES
11.3.4
ORTHOBIOLOGICS
11.3.5
FRACTURE FIXATION
11.3.5.1
BONE PLATES
11.3.5.2
SCREWS
11.3.5.3
PINS
11.3.5.4
RODS
11.3.5.5
WIRES
11.4
OPHTHALMOLOGY
11.4.1
CONTACT LENSES
11.4.2
INTRAOCULAR LENSES
11.4.3
FUNCTIONAL REPLACEMENTS OF OCULAR TISSUES
11.4.4
SYNTHETIC CORNEAS
11.4.5
OTHER OPHTHALMOLOGY APPLICATIONS
11.5
DENTAL
11.5.1
DENTAL IMPLANTS
11.5.2
DENTAL BONE GRAFTS & SUBSTITUTES
11.5.3
DENTAL MEMBRANES
11.5.4
TISSUE REGENERATION MATERIALS
11.6
PLASTIC SURGERY
11.6.1
SOFT-TISSUE FILLERS
11.6.2
CRANIOFACIAL SURGERY
11.6.3
FACIAL WRINKLE TREATMENT
11.6.4
BIOENGINEERED SKINS
11.6.5
PERIPHERAL NERVE REPAIR
11.6.6
ACELLULAR DERMAL MATRICES
11.7
WOUND HEALING
11.7.1
WOUND CLOSURE DEVICES
11.7.1.1
SUTURES
11.7.1.2
STAPLES
11.7.2
INTERNAL TISSUE SEALANTS
11.7.3
SURGICAL HEMOSTATS
11.7.4
ADHESION BARRIERS
11.7.5
HERNIA MESHES
11.7.6
SKIN SUBSTITUTES
11.8
TISSUE ENGINEERING
11.8.1
SCAFFOLDS FOR BIOMATERIALS
11.8.2
NANOMATERIALS FOR BIOSENSING
11.8.3
TAILORING OF INORGANIC NANOPARTICLES
11.9
NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS
11.9.1
SHUNTING SYSTEMS
11.9.2
CORTICAL NEURAL PROSTHETICS
11.9.3
HYDROGEL SCAFFOLDS FOR CNS REPAIR
11.9.4
NEURAL STEM CELL ENCAPSULATION
11.10
URINARY APPLICATIONS
11.10.1
URINARY CATHETERS
11.10.2
URETHRAL STENTS
11.10.3
OTHERS
11.11
OTHER APPLICATIONS
11.11.1
DRUG DELIVERY SYSTEMS
11.11.2
GASTROINTESTINAL APPLICATIONS
11.11.3
BARIATRIC SURGERY
12
GLOBAL BIOMATERIALS MARKET, BY REGION, 2023-2030 (USD MILLION)
ASSESSMENT OF GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY GEOGRAPHIES AND COUNTRIES
12.1
INTRODUCTION
12.2
NORTH AMERICA
12.2.1
US
12.2.2
CANADA
12.2.3
MACROECONOMIC OUTLOOK OF NORTH AMERICA
12.3
EUROPE
12.3.1
GERMANY
12.3.2
UK
12.3.3
FRANCE
12.3.4
ITALY
12.3.5
SPAIN
12.3.6
REST OF EUROPE
12.3.7
MACROECONOMIC OUTLOOK OF EUROPE
12.4
ASIA PACIFIC
12.4.1
CHINA
12.4.2
JAPAN
12.4.3
INDIA
12.4.4
SOUTH KOREA
12.4.5
AUSTRALIA
12.4.6
REST OF ASIA PACIFIC
12.4.7
MACROECONOMIC OUTLOOK OF ASIA PACIFIC
12.5
LATIN AMERICA
12.5.1
BRAZIL
12.5.2
MEXICO
12.5.3
REST OF LATIN AMERICA
12.5.4
MACROECONOMIC OUTLOOK OF LATIN AMERICA
12.6
MIDDLE EAST
12.6.1
GCC
12.6.1.1
UAE
12.6.1.2
SAUDI ARABIA
12.6.1.3
REST OF GCC
12.6.2
REST OF MIDDLE EAST
12.6.3
MACROECONOMIC OUTLOOK OF MIDDLE EAST
12.7
AFRICA
12.7.1
MACROECONOMIC OUTLOOK OF AFRICA
13
COMPETITIVE LANDSCAPE
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
13.1
INTRODUCTION
13.2
KEY PLAYERS STRATEGY/ RIGHT TO WIN
13.3
REVENUE ANALYSIS, 2022-2024
13.4
MARKET SHARE ANALYSIS,
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
13.5.1
STARS
13.5.2
EMERGING LEADERS
13.5.3
PERVASIVE PLAYERS
13.5.4
PARTICIPANTS
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
13.5.5.1
COMPANY FOOTPRINT
13.5.5.2
REGION FOOTPRINT
13.5.5.3
PRODUCT FOOTPRINT
13.5.5.4
STERILITY TYPE FOOTPRINT
13.5.5.5
APPLICATION FOOTPRINT
13.6
COMPANY EVALUATION MATRIX: START-UPS/SMES,
13.6.1
PROGRESSIVE COMPANIES
13.6.2
RESPONSIVE COMPANIES
13.6.3
DYNAMIC COMPANIES
13.6.4
STARTING BLOCKS
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
13.6.5.1
DETAILED LIST OF KEY STARTUPS/ SMES
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
13.7
COMPETITIVE SCENARIO
13.7.1
PRODUCT LAUNCHES
13.7.2
DEALS
13.7.3
OTHER DEVELOPMENTS
13.8
BRAND/ PRODUCT COMPARATIVE ANALYSIS
13.9
VALUATION AND FINANCIAL METRICS
14
COMPANY PROFILES
14.1
KEY COMPANIES
14.1.1
BASF SE
14.1.2
COVESTRO AG
14.1.3
CELANESE CORPORATION
14.1.4
CARPENTER TECHNOLOGY CORPORATION.
14.1.5
EVONIK INDUSTRIES AG
14.1.6
DSM
14.1.7
CORBION NV
14.1.8
VICTREX PLC
14.1.9
CERAMTEC GMBH
14.1.10
MITSUBISHI CHEMICAL CORPORATION
14.1.11
COORSTEK INC.
14.1.12
BERKELEY ADVANCED BIOMATERIALS
14.1.13
CAM BIOCERAMICS B.V
14.1.14
ZEUS COMPANY INC
14.1.15
AMETEK INC
14.16
GELITA AG
14.2
OTHER PLAYERS
14.2.1
COLLAGEN SOLUTIONS LLC
14.2.2
BIOCOMPOSITES
14.2.3
NOBLE BIOMATERIALS, INC
14.2.4
REGENITY
14.2.5
KURARAY CO., LTD
14.2.6
SOLESIS
14.2.7
INSTITUT STRAUMANN AG
14.2.8
FOSTER CORPORATION
14.2.9
CDI PRODUCTS
15
RESEARCH METHODOLOGY
15.1
RESEARCH DATA
15.1.1
SECONDARY DATA
15.1.1.1
KEY SOURCES OF SECONDARY DATA
15.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
15.1.2
PRIMARY DATA
15.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS
15.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
15.2
MARKET SIZE ESTIMATION
15.2.1
GLOBAL BIOMATERIALS MARKET SIZE ESTIMATION
15.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
15.2.1.2
MNM REPOSITORY ANALYSIS
15.2.1.3
SECONDARY ANALYSIS
15.2.1.4
PRIMARY RESEARCH
15.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
15.3
MARKET GROWTH RATE PROJECTIONS
15.4
DATA TRIANGULATION
15.6
RESEARCH ASSUMPTIONS
15.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
16
APPENDIX
16.1
DISCUSSION GUIDE
16.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
AVAILABLE CUSTOMIZATIONS
16.4
RELATED REPORTS
16.5
AUTHOR DETAILS
Methodology
This study involved four major activities in estimating the current size of the biomaterials market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the biomaterials market. The secondary sources used for this study include the Journal of Biomedical Nanotechnology, Journal of Materials Science, Materials Science and Engineering, Journal of Biomedical Materials Research, Biomedical Engineering Society (BMES), Annual Reports, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, global product revenues, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data was collected and analyzed to arrive at the overall size of the global biomaterials market, which was validated through primary research.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
Note: Tiers are defined based on a company’s total revenue. As of 2023, Tier 1 = >USD 1 Bn, Tier 2 = USD 500 Mn to USD 1 Bn, and Tier 3 <USD 500 Mn.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the biomaterials market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The major players in the industry and market have been identified through extensive primary and secondary research.
- The product and company revenues generated from the biomaterials business of players operating in the market have been determined through secondary research and primary analysis.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Market Size Estimation Methodology-Bottom-up approach
To know about the assumptions considered for the study, Request for Free Sample Report
Top-down Approach-
Data Triangulation
After estimating the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Biomaterials refer to substances that have been engineered to interact with biological systems for medical purposes. These materials are designed to be compatible with living tissues and can be used in various medical applications, such as implants, prosthetics, drug delivery systems, and tissue engineering. The primary goal of biomaterials is to enhance or replace the function of a body part, promote healing, and improve overall health. These materials are selected and engineered based on their biocompatibility, mechanical properties, and ability to integrate seamlessly with the biological environment. Biomaterials play a crucial role in advancing medical technologies and improving patient outcomes.
Key Stakeholders
- Biomaterial product manufacturing companies
- Healthcare service providers (including hospitals & specialty clinics)
- National and regional research boards and organizations
- Research & development companies
- Clinical research organizations (CROs)
- Healthcare technology companies
- Biotechnology companies
- Research laboratories & academic institutes
- Market research & consulting firms
- Regulatory bodies
The main objectives of this study are as follows:
- To define, describe, and forecast the biomaterials market by type, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall biomaterials market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), the Middle East {GCC [Saudi Arabia (KSA), United Arab Emirates (UAE), and the Rest of GCC] and the Rest of Middle East}, and Africa
- To profile the key players and analyze their market shares and core competencies
- To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
- To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report with additional efforts:
Product-Level Information
Country-wise Information:
- Analysis for additional countries (up to five)
Company Information:
- Detailed analysis and profiling of additional key market players across the globe
Still Researching the
Biomaterials Ecosystem?
See the competitors, opportunities, and growth signals shaping it - instantly.
Generate 15+ consulting-grade strategic insights tailored to your growth question.
Explore Biomaterials Intelligence
Powered by 17 years of MarketsandMarkets intelligence